Skip to main content
Clinical Trials/DRKS00009605
DRKS00009605
Completed
未知

The effect of a ketogenic diet (KD) - a very low carbohydrate and high-fat diet - without caloric restrictions on endurance capacity in healthy adults. - KetoPerformance

niversitätsklinikum Freiburg; Klinik für Innere medizin I; Hämatologie, Onkologie und Stammzelltransplantation0 sites42 target enrollmentJanuary 8, 2016

Overview

Phase
未知
Intervention
Not specified
Conditions
Healthy participants
Sponsor
niversitätsklinikum Freiburg; Klinik für Innere medizin I; Hämatologie, Onkologie und Stammzelltransplantation
Enrollment
42
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 8, 2016
End Date
July 7, 2016
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversitätsklinikum Freiburg; Klinik für Innere medizin I; Hämatologie, Onkologie und Stammzelltransplantation

Eligibility Criteria

Inclusion Criteria

  • ?Age \>18 years
  • ?Body mass index 19\-30 kg/m2
  • ?Weight loss \<5% of body weight in the last 6 months
  • ?Adequate renal function (serum creatinine \< 1\.5 X UNL \[upper normal limit] or creatinine clearance \> 50 ml/min)
  • ?Adequate liver function: bilirubin \= 1\.5 x upper limit of normal (UNL) range, ALAT and/or ASAT \= 2\.5 x UNL, Alkaline Phosphatase \=5 x UNL
  • ?Written informed consent

Exclusion Criteria

  • Known G6PD (glucose\-6\-phosphate dehydrogenase) deficiency
  • Diabetes mellitus undergoing therapy with insulin or oral agents
  • Kidney stones
  • Pregnant or lactating women
  • Disorders of fatty acid metabolism: carnitine deficiency (primary), carnitine palmitoyltransferase (CPT) I or II deficiency, carnitine translocase deficiency, ß\-oxidation defects, short\-chain acyl dehydrogenase deficiency (SCAD), medium\-chain acyl dehydrogenase deficiency (MCAD), long\-chain acyl dehydrogenase deficiency (LCAD), medium\-chain 3\-hydroxyacyl\-CoA deficiency, long\-chain 3\-hydroxyacyl\-CoA deficiency, pyruvate carboxylase deficiency, porphyria

Outcomes

Primary Outcomes

Not specified

Similar Trials